SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-354132
Filing Date
2021-12-10
Accepted
2021-12-10 17:25:07
Documents
19
Period of Report
2021-12-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d124536d8k.htm   iXBRL 8-K 35519
2 EX-4.1 d124536dex41.htm EX-4.1 58555
3 EX-4.2 d124536dex42.htm EX-4.2 59015
4 EX-4.3 d124536dex43.htm EX-4.3 61785
5 EX-4.4 d124536dex44.htm EX-4.4 58329
6 EX-4.5 d124536dex45.htm EX-4.5 60139
7 EX-5.1 d124536dex51.htm EX-5.1 6518
  Complete submission text file 0001193125-21-354132.txt   586742

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA mrk-20211210.xsd EX-101.SCH 4748
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mrk-20211210_def.xml EX-101.DEF 14421
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrk-20211210_lab.xml EX-101.LAB 24144
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrk-20211210_pre.xml EX-101.PRE 15519
12 EXTRACTED XBRL INSTANCE DOCUMENT d124536d8k_htm.xml XML 8356
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

IRS No.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06571 | Film No.: 211486363
SIC: 2834 Pharmaceutical Preparations